Dan Maziasz

Company: Kyverna Therapeutics, Inc.

Job title: Chief Business Officer

Seminars:

Unlocking New Immune Pathways: Discussing B-Cell Depletion & Beyond in Autoimmune Therapy 9:10 am

Discussing the latest B-cell depletion data across diseases to assess effectiveness and potential for expansion into dermatological diseases such as psoriasis Evaluating if B-cell depletion remains the most promising approach and exploring the potential to move beyond B-cell targeting (including, Mast Cells, T-cells, Macrophages, Myeloid Cells and more) Exploring immune cell depletion across disease indications…Read more

day: Day Two